TANDEM DIABETES CARE INC business relationships
Companies named in TANDEM DIABETES CARE INC’s 10-K filed 2026-02-19, and public companies whose annual reports name TANDEM DIABETES CARE INC. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 6.6 / 10
- AI naming
- 100 / 100 Top 1% in its category
- Agent readiness
- 10 / 100
- AI adoption
- 0 / 100
Named in TANDEM DIABETES CARE INC’s annual report 3
“On May 21, 2025, the Company and various Roche entities (collectively "Roche") entered into a Settlement, Mutual Release and Cross-License Agreement (the "Roche Cross-License Agreement").” SEC filing
“There can be no assurance that our collaborations with Dexcom and Abbott will be successful or that we will not experience delays, business disputes, or other unanticipated challenges.” SEC filing
“There can be no assurance that our collaborations with Dexcom and Abbott will be successful or that we will not experience delays, business disputes, or other unanticipated challenges.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.